{
    "xml": "<topic id=\"PHP80915\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/sinemet-cr\" basename=\"sinemet-cr\" title=\"Sinemet CR\">\n<title>Sinemet<tm tmtype=\"reg\"/> CR</title>\n<topic id=\"PHP81134\" outputclass=\"indicationsAndDose\" rev=\"1.14\" parent=\"/clinical-medicinal-product-information/sinemet-cr\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor therapy)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1&#8239;tablet twice daily, both dose and interval then adjusted according to response at intervals of not less than 3 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;tablet twice daily, dose can be substituted for a daily dose of levodopa 300&#8211;400&#8239;mg in immediate-release <i>Sinemet</i>\n<tm tmtype=\"reg\"/> tablets (substitute <i>Sinemet</i>\n<tm tmtype=\"reg\"/>\n<i>CR</i> to provide approximately 10% more levodopa per day and extend dosing interval by 30&#8211;50%); dose and interval then adjusted according to response at intervals of not less than 3 days.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP80915",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/sinemet-cr",
    "basename": "sinemet-cr",
    "title": "Sinemet CR",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor therapy)",
                        "html": "Parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor therapy)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 1 tablet twice daily, both dose and interval then adjusted according to response at intervals of not less than 3 days.",
                        "html": "<p>Initially 1&#8239;tablet twice daily, both dose and interval then adjusted according to response at intervals of not less than 3 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)",
                        "html": "Parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 tablet twice daily, dose can be substituted for a daily dose of levodopa 300&#8211;400 mg in immediate-release Sinemet tablets (substitute Sinemet CR to provide approximately 10% more levodopa per day and extend dosing interval by 30&#8211;50%); dose and interval then adjusted according to response at intervals of not less than 3 days.",
                        "html": "<p>1&#8239;tablet twice daily, dose can be substituted for a daily dose of levodopa 300&#8211;400&#8239;mg in immediate-release <i>Sinemet</i> <tm tmtype=\"reg\"/> tablets (substitute <i>Sinemet</i> <tm tmtype=\"reg\"/> <i>CR</i> to provide approximately 10% more levodopa per day and extend dosing interval by 30&#8211;50%); dose and interval then adjusted according to response at intervals of not less than 3 days.</p>"
                    }
                ]
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}